Advances in the application of recombinant herpesvirus-vectored vaccines in animal disease control
Frontiers in Microbiology · 21.07.2026 · 17
DOI: 10.3389/fmicb.2026.1888296 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 21.07.2026. Verfasst von Jiahui Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory for Prevention and Control of Infectious Diseases in Livestock and Poultry, Beijing, China. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Academy of Agricultural and Forestry Sciences.
Abstract (Originalsprache)
Recombinant herpesvirus vectors have emerged as highly potent platforms for next-generation vaccine development, distinguished by their genomic capacity and their unique ability to elicit durable, long-lasting immunity through persistent latent infections. In this review, we trace the evolutionary trajectory of herpesvirus vector engineering—transitioning from traditional homologous recombination to advanced bacterial artificial chromosome (BAC) systems and precise, scarless CRISPR/Cas9 gene editing. We comprehensively evaluate the rational design of classical animal herpesvirus vectors, including pseudorabies virus (PRV), herpesvirus of turkeys (HVT), and feline herpesvirus type 1 (FHV-1). Specifically, we highlight their distinct advantages in molecular attenuation, the optimization of non-essential insertion loci, and the application of tissue-specific promoters for multiplexed antigen presentation. Furthermore, we discuss the strategic deployment of multivalent herpesvirus vaccines within the “One Health” framework, emphasizing their critical role in simplifying immunization protocols and interrupting the transmission chains of zoonotic diseases. Finally, we address the prevailing translational bottlenecks, including scalable manufacturing challenges and stringent regulatory frameworks regarding environmental release, providing perspectives on how continuous biotechnological innovations will empower herpesvirus vectors to serve as formidable prophylactic tools against emerging and re-emerging infectious diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing Key Laboratory for Prevention and Control of Infectious Diseases in Livestock and Poultry, Beijing, China.
- Institute of Animal Husbandry and Veterinary Medicine, Beijing Academy of Agriculture and Forestry Sciences, Beijing, China.
- The Platform of Youth Innovation, Institute of Animal Husbandry and Veterinary Medicine, Beijing Academy of Agricultural and Forestry Sciences, Beijing, China.
- College of Life Sciences and Food Engineering, Hebei University of Engineering, Handan, Hebei, China.
- College of Life Sciences, Henan Normal University, Xinxiang, Henan, China.
Förderung
- Beijing Academy of Agricultural and Forestry Sciences
Zitieren
APA
Guo, J., Mei, C., Sun, X., Lin, Q., Bu, W., Xie, S., & Jiang, B. (2026). Advances in the application of recombinant herpesvirus-vectored vaccines in animal disease control. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1888296
Vancouver
Guo J, Mei C, Sun X, Lin Q, Bu W, Xie S, et al. Advances in the application of recombinant herpesvirus-vectored vaccines in animal disease control. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1888296
BibTeX
@article{Guo2026,
author = {Guo, Jiahui and Mei, Chen and Sun, Xinyao and Lin, Qiuhui and Bu, Weidong and Xie, Shijie and Jiang, Bo},
title = {Advances in the application of recombinant herpesvirus-vectored vaccines in animal disease control},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1888296}
}
EUVIMED